88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

The Galien Foundation Announces the Nominees for the Inaugural 2026 Prix Galien Korea Awards Historic First Edition Launches in Partnership with MK Media (Maekyung), Yozma Group Korea, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), and KoreaBIO at the World Knowledge ... 2026-09-03T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
AAHRPP Accredits Five More Research Entities 21 more organizations earn reaccreditation ... 2026-09-03T Biotechnology Health Care/Hospital Higher Education Medical/Pharmaceuticals
Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC HONG KONG , Sept. 3, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that a pre-specified interim analysis of overall survival (OS) in the HARMONi-2 ... 2026-09-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction PROVIDENCE, R.I. , Sept. 3, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™ , its proprietary in silico platform for assessing the immunogenicity ... 2026-09-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreement signed this year further accelerating the ... 2026-09-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life - Spinal Cord Research ... 2026-09-02T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC WUXI, China , Sept. 2, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY) , a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that it has received regulatory ... 2026-09-02T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system AUSTIN, Texas , Sept. 2, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first facility in the nation to participate in a clinical ... 2026-09-02T Biotechnology Health Care/Hospital Medical Equipment
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. Telix has positively engaged with the FDA ... 2026-09-02T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026 Haier Biomedical Accelerates Its Transformation into an Intelligent Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026 ... 2026-09-01T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved